Apeloa Pharmaceutical (000739.SZ): Tazobactam obtained approval for the market application of chemical raw materials.

Prolo Pharmaceutical Co., Ltd. (000739.SZ) announced that its wholly-owned subsidiary, Zhejiang Prolo DeBang Pharmaceutical Co., Ltd., recently received the "Approval Notification for the Market Launch Application of Chemical Raw Materials" for Cefotolan Pivoxil issued by the National Medical Products Administration (referred to as "NMPA"). The approval for the market launch of the company's Cefotolan Pivoxil raw materials marks that this product is qualified for sale in the domestic market, broadens the company's product pipeline, helps further expand the company's raw materials business, and advances the strategic development of refining raw materials, which has certain positive significance for the company's future development.